|
|
|
|
Vol. 61, Issue 2, 407-414, February 2002
Department of Pharmacology, Medical Faculty, University of
Tübingen, Tübingen, Germany
Sulfonylurea receptors (SURs) are
subunits of ATP-sensitive K+ channels (KATP
channels); they mediate the channel-closing effect of sulfonylureas
such as glibenclamide and the channel-activating effect of
KATP channel openers such as the pinacidil analog P1075. We
investigated the inhibition by MgATP and P1075 of glibenclamide binding
to SUR2B, the SUR subtype in smooth muscle. To increase specific
binding, experiments were also performed using SUR2B(Y1206S), a mutant
with higher affinity for glibenclamide than for the wild-type (KD = 4 versus 22 nM,
respectively) but otherwise exhibiting similar pharmacological
properties. In the absence of MgATP, [3H]glibenclamide
binding to both SURs was homogenous. MgATP inhibited [3H]glibenclamide binding to both SURs to 25% by
reducing the apparent number of glibenclamide binding sites, leaving
the affinity unchanged. In the absence of MgATP, P1075 inhibited
[3H]glibenclamide binding in a monophasic manner with
Ki
1 µM. In the presence of MgATP (1 mM), inhibition was biphasic with one Ki
value resembling the true affinity of P1075 for SUR2B (2-6 nM) and the
other resembling Ki in the absence of MgATP
(
1 µM). The data show that (1) MgATP induces heterogeneity in the
glibenclamide sites; (2) the high-affinity glibenclamide sites
remaining with MgATP are linked to two classes of P1075 sites; and (3)
P1075 interacts specifically with SUR2B also in the absence of MgATP. The data are discussed with the assumption that SUR2B, expressed alone,
forms tetramers; that MgATP induces allosteric interactions between the
subunits; and that mixed SUR2B-glibenclamide-P1075 complexes can exist
at equilibrium.
This article has been cited by other articles:
![]() |
M. Winkler, D. Stephan, S. Bieger, P. Kuhner, F. Wolff, and U. Quast Testing the Bipartite Model of the Sulfonylurea Receptor Binding Site: Binding of A-, B-, and A + B-Site Ligands J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 701 - 708. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hambrock, T. Kayar, D. Stumpp, and H. Osswald Effect of Two Amino Acids in TM17 of Sulfonylurea Receptor SUR1 on the Binding of ATP-Sensitive K+ Channel Modulators Diabetes, December 1, 2004; 53(suppl_3): S128 - S134. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Proks, F. Reimann, N. Green, F. Gribble, and F. Ashcroft Sulfonylurea Stimulation of Insulin Secretion Diabetes, December 1, 2002; 51(90003): S368 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Lange, C. Loffler-Walz, H. C. Englert, A. Hambrock, U. Russ, and U. Quast The Stereoenantiomers of a Pinacidil Analog Open or Close Cloned ATP-sensitive K+ Channels J. Biol. Chem., October 18, 2002; 277(43): 40196 - 40205. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. K. Hansen, I. T. Christensen, J. B. Hansen, R. D. Carr, F. M. Ashcroft, and P. Wahl Differential Interactions of Nateglinide and Repaglinide on the Human {beta}-Cell Sulphonylurea Receptor 1 Diabetes, September 1, 2002; 51(9): 2789 - 2795. [Abstract] [Full Text] [PDF] |
||||